CARBOGEN AMCIS Drug Product Manufacturing Site - GMP Certified
CARBOGEN AMCIS has secured GMP certification for its state-of-the-art sterile Drug Product facility in Saint-Beauzire, France, following a successful ANSM inspection in January 2025. Fully compliant with the latest EU GMP Annex 1 standards, the site features advanced aseptic manufacturing capabilities, including highly potent compounds and antibody-drug conjugates. With cutting-edge technology and a dedicated team, CARBOGEN AMCIS continues to support customers in bringing innovative therapies to market.
For more information download our ADC and Bioconjugation brochure or contact us today.
